PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Compound Formula Rehmannia alleviates dyskinesia in Parkinson's disease

2014-05-05
(Press-News.org) Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia. They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease by modulating neurotransmitter signaling in the corpus striatum. The relevant article has been published in the Neural Regeneration Research (Vol. 9, No. 4, 2014).

INFORMATION: Article: " Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease," by Long Teng, Fang Hong, Chenguang Zhang, Jiancheng He, Haiying Wang (Shanghai University of Traditional Chinese Medicine, Shanghai, China) Teng L, Hong F, Zhang CG, He JC, Wang HY. Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease. Neural Regen Res. 2014;9(4):407-412.

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/


ELSE PRESS RELEASES FROM THIS DATE:

New idea for hearing improvement in patients with hearing aids under background noise

2014-05-05
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present. Researchers think that a poor ability to localize sound in a complex auditory environment is responsible for the weak speech perception observed under these conditions. Pentobarbital anesthesia prolongs the recovery time of responses to lagging stimulus. The effects of pentobarbital anesthesia on the precedence effect stem from decreased dissociation of gamma-aminobutyric acid from its receptor (i.e., it ...

When highest perceptual ability occurs in a day?

2014-05-05
Many previous chronobiological studies have reported on detection of circadian fluctuation in performing simple motor tasks, fine skilled movement, and anaerobic exercise. However, to the best of our knowledge, literature concerning variation of sensory function according to the circadian cycle is lacking. Therefore, Yong Hyun Kwon and co-workers from Yeungnam University College of Science and Technology in Republic of Korea observed and compared the circadian fluctuations in tactile sense, joint reposition sense and two-point discrimination in 21healthy adult subjects ...

PQ disconnection with the activity of isolated PTO nerve tissue for seizure control

PQ disconnection with the activity of isolated PTO nerve tissue for seizure control
2014-05-05
Diffuse lesions involving the posterior quadrant (PQ) of the cerebral hemisphere (temporal, parietal, and occipital lobes) induce intractable epilepsy. These patients are potential candidates for surgical treatment. Maintenance of isolated nerve tissue activity after surgery plays a crucial role in the neuroprotective effects of neurosurgery treatment. Shaoya Yin and colleagues from Tianjin Huanhu Hospital in China selected two patients with temporal-parietal-occipital (PTO) intractable epilepsy to receive posterior quadrant disconnection. Postoperative MRI scans of the ...

A first: Nuclear transfer to reprogram adult patient cells into stem cells

A first: Nuclear transfer to reprogram adult patient cells into stem cells
2014-05-05
Jerusalem, May 4, 2014 -- The capacity to reprogram adult patient cells into pluripotent, embryonic-like, stem cells by nuclear transfer has been reported as a breakthrough by scientists from the US and the Hebrew University of Jerusalem. The work, described in the journal Nature, was accomplished by researchers from the New York Stem Cell Foundation Research Institute and Columbia University and by Nissim Benvenisty, the Herbert Cohn professor of Cancer Research and director of the Stem Cell Unit at the Institute of Life Sciences at the Hebrew University of Jerusalem, ...

Glutamine ratio is key ovarian cancer indicator

Glutamine ratio is key ovarian cancer indicator
2014-05-05
HOUSTON -- (May 5, 2014) -- A Rice University-led analysis of the metabolic profiles of hundreds of ovarian tumors has revealed a new test to determine whether ovarian cancer cells have the potential to metastasize, or spread to other parts of the body. The study also suggests how ovarian cancer treatments can be tailored based on the metabolic profile of a particular tumor. The research, which appears online this week in Molecular Systems Biology, was conducted at the Texas Medical Center in Houston by researchers from Rice, the University of Texas MD Anderson Cancer ...

New technique tracks proteins in single HIV particle

2014-05-05
An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique allows scientists to study the life-threatening virus in detail and makes screening potential anti-HIV drugs quicker and more efficient. The technique can also be used to study other diseases. Understanding how the human immunodeficiency virus (HIV) reproduces itself is crucial in the effort to fight the disease. Upon entering the bloodstream, HIV viral particles, or ...

Low testosterone levels may indicate worsening of disease for men with prostate cancer

2014-05-05
For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease. That's the conclusion of a new study published in BJU International. The findings may help physicians identify patients with low-risk prostate cancer who should receive aggressive anticancer treatment. Men with prostate cancer that is not life threatening and is only slowly progressing, can often forego treatment and instead undergo active surveillance. This involves close monitoring to ensure that their disease does not become serious and jeopardize their health. ...

Stigma: At the root of ostracism and bullying

2014-05-05
VANCOUVER, BRITISH COLUMBIA – Increasing evidence shows that stigma – whether due to a child's weight, sexual orientation, race, income or other attribute -- is at the root of bullying, and that it can cause considerable harm to a child's mental health. Experts in pediatric mental health, bullying and ostracism will gather May 5 for a symposium titled "Stigma, Ostracism and Bullying: Dangers, Prevention and Interventions" at the Pediatric Academic Societies Annual Meeting in Vancouver, British Columbia. Researchers will present evidence of stigma associated with various ...

Being born 4-6 weeks premature can affect brain structure, function

2014-05-05
VANCOUVER, BRITISH COLUMBIA – The brains of children who were born just a few weeks early differ from those born on time, and these differences may affect learning and behavior, according to a study to be presented Monday, May 5, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada. Studies have shown that children who were born between 34 and 36 weeks' gestation (late preterm) have more social, behavioral and academic problems than children born at full term (37-41 weeks). However, few studies have looked at the brain structure ...

Electronic tool helps reduce drug errors among hospitalized children

2014-05-05
VANCOUVER, BRITISH COLUMBIA – When children are admitted to the hospital, sometimes the medications they take at home are lost in the shuffle, or they may be given the wrong dose. Having a system in place at hospital admission to record and review a child's medication history results in fewer errors, potentially avoiding harm to the patient, according to a study to be presented Monday, May 5, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada. The Joint Commission, which accredits and certifies more than 20,000 health care ...

LAST 30 PRESS RELEASES:

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

[Press-News.org] Compound Formula Rehmannia alleviates dyskinesia in Parkinson's disease